Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.6 USD | +4.15% | +12.63% | +159.69% |
05-09 | Q32 Bio Inc. Provides Corporate Update | CI |
04-11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+159.69% | 339M | |
+7.38% | 111B | |
+11.13% | 106B | |
-12.46% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.79% | 16.81B | |
+37.54% | 12.54B | |
-24.36% | 8.09B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Chardan Trims Homology Medicines' Price Target to $14 From $15, Reiterates Buy Rating